Articles

According to a new trial, just 15 minutes of Individualized, physician-directed lifestyle counseling appears to help diabetic patients increase physical activity and lose weight.

On January 18, the FDA approved a new indication for colesevelam HCl 625-mg tablets as adjunctive therapy to improve glycemic control in adults with type 2 diabetes. Colesevelam can be added to metformin, sulfonylureas, or insulin, either alone or in combination with other antidiabetic agents.

The results of the study over three years confirms that optimal diabetes care requires a team effort.

New research suggests that individuals with a high body mass index (BMI) and high systolic blood pressure are at an increased risk for stroke mortality.

Researchers have discovered new cellular mechanisms that lead to in insulin resistance in people with diabetes.

For critically ill patients, intensive insulin therapy (IIT) to keep blood sugar (glucose) at normal levels reduces the risk of acute kidney injury, reports a new study.

Neurological evaluation of diabetics indicates that there is relationship between diminished vascular endothelial growth factor (VEGF) expression and neuropathy.

Medtronic Inc said U.S. health regulators approved its blood sugar monitoring device, the CGMS iPro Recorder. The U.S. medical device maker said patients wear the device for three days, after which physicians can review the data and use the results to uncover glucose patterns.

According to a new study, a simple physician counseling process during usual care visits is effective in encouraging sedentary overweight or obese patients with type 2 diabetes to have a healthier lifestyle. “Patients reported that support from their physician was the most important component of the intervention.”

Caffeine in even moderate doses may impair glucose control in type 2 diabetes, researchers report. Consuming equivalent of 4 cups a day led to spikes in blood sugar levels of 8%.